文献速递睡眠呼吸障碍

阻塞性睡眠呼吸暂停、缺氧与非酒精性脂肪性肝病

Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01

综述指出阻塞性睡眠呼吸暂停(OSA)与非酒精性脂肪性肝病(NAFLD)相关,且独立于肥胖等共同风险因素;关联与夜间低氧血症程度有关,动物模型聚焦间歇低氧机制;但临床筛查策略仍不明确,需进一步试验。

要点

  • OSA与NAFLD相关,独立于肥胖等共同风险因素。
  • OSA-NAFLD关联与夜间低氧血症程度相关。
  • 间歇低氧可致氧化应激、炎症、交感激活等,参与NAFLD发生发展。

核心结论

  • OSA与NAFLD存在关联,且独立于肥胖或其他共同风险因素,关联与夜间低氧血症程度相关。

研究设计与样本

  • 综述,整合动物与人类研究证据,探讨OSA与NAFLD关系并倡导进一步试验。

主要发现

  • 间歇低氧可导致组织缺氧,并引起氧化应激、线粒体功能障碍、炎症及交感神经系统过度激活等不良适应效应。
  • 动物模型中间歇低氧可导致胰岛素抵抗、肝脏脂质代谢关键步骤功能障碍、动脉粥样硬化及肝脂肪变和纤维化。

临床怎么用

  • 临床需关注OSA患者NAFLD风险及NAFLD患者OSA风险,但筛查强度尚无明确证据。

局限性

  • OSA患者NAFLD筛查及反向筛查的积极程度等关键问题仍未解答,需进一步试验明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent studies have demonstrated that obstructive sleep apnea (OSA) is associated with the development and evolution of nonalcoholic fatty liver disease (NAFLD), independent of obesity or other shared risk factors. Like OSA, NAFLD is a prevalent disorder associated with major adverse health outcomes: Patients with NAFLD may develop cirrhosis, liver failure, and hepatocellular carcinoma. One major finding that has emerged from these studies is that the OSA-NAFLD association is related to the degree of nocturnal hypoxemia in OSA. Animal models have therefore largely focused on intermittent hypoxia, a key manifestation of OSA, to shed light on the mechanisms by which OSA may give rise to the complex metabolic disturbances that are seen in NAFLD. Intermittent hypoxia leads to tissue hypoxia and can result in oxidative stress, mitochondrial dysfunction, inflammation, and overactivation of the sympathetic nervous system, among many other maladaptive effects. In such models, intermittent hypoxia has been shown to cause insulin resistance, dysfunction of key steps in hepatic lipid metabolism, atherosclerosis, and hepatic steatosis and fibrosis, each of which is pertinent to the development and/or progression of NAFLD. However, many intriguing questions remain unanswered: Principally, how aggressively should the clinician screen for NAFLD in patients with OSA, and vice versa? In this review, we attempt to apply the best evidence from animal and human studies to highlight the relationship between these two disorders and to advocate for further trials aimed at defining these relationships more precisely.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Mesarwi OA, Loomba R, Malhotra A, et al. Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease. Am J Respir Crit Care Med. 2019. PMID: 30422676. doi:10.1164/rccm.201806-1109TR

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。